These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 24463311)
21. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. Herrington DM; Reboussin DM; Brosnihan KB; Sharp PC; Shumaker SA; Snyder TE; Furberg CD; Kowalchuk GJ; Stuckey TD; Rogers WJ; Givens DH; Waters D N Engl J Med; 2000 Aug; 343(8):522-9. PubMed ID: 10954759 [TBL] [Abstract][Full Text] [Related]
22. Commentary on "menopausal hormone treatment in postmenopausal women: risks and benefits". Archer DF South Med J; 2014 Nov; 107(11):696-7. PubMed ID: 25365436 [No Abstract] [Full Text] [Related]
23. Hormone replacement therapy. Med Lett Drugs Ther; 2002 Sep; 44(1138):78. PubMed ID: 12238487 [No Abstract] [Full Text] [Related]
24. [Effect of conjugated estrogen and Org OD14 on serum lipoprotein and apolipoprotein in perimenopausal and postmenopausal women]. Bai W; Yang X; Zheng S Zhonghua Fu Chan Ke Za Zhi; 1999 May; 34(5):293-6. PubMed ID: 11326938 [TBL] [Abstract][Full Text] [Related]
25. [Plasma estrogen levels in postmenopausal women treated with estrogens alone or combined with medroxyprogesterone acetate in the same tablet]. Gadán A Rev Chil Obstet Ginecol; 1992; 57(4):283-6. PubMed ID: 1342454 [TBL] [Abstract][Full Text] [Related]
26. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women. Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210 [TBL] [Abstract][Full Text] [Related]
27. Consortium for the Assessment of Research on Progestins and Estrogens (CARPE) Fort Worth, Texas August 1-3, 2003. Simpkins JW; Singh M J Womens Health (Larchmt); 2004 Dec; 13(10):1165-8. PubMed ID: 15650349 [No Abstract] [Full Text] [Related]
28. Effect of vitamin E supplementation with and without hormone therapy on circulatory inflammatory markers in postmenopausal women. Carr BR; Khan N; Adams-Huet B; Kakarla N; Havelock JC; Gell J Fertil Steril; 2006 Mar; 85(3):667-73. PubMed ID: 16500336 [TBL] [Abstract][Full Text] [Related]
29. Estrogen plus progestin and colorectal cancer in postmenopausal women. Chlebowski RT; Wactawski-Wende J; Ritenbaugh C; Hubbell FA; Ascensao J; Rodabough RJ; Rosenberg CA; Taylor VM; Harris R; Chen C; Adams-Campbell LL; White E; N Engl J Med; 2004 Mar; 350(10):991-1004. PubMed ID: 14999111 [TBL] [Abstract][Full Text] [Related]
30. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease. Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047 [TBL] [Abstract][Full Text] [Related]
31. Effect of oral conjugated equine estrogen combined with medroxyprogesterone acetate on plasma homocysteine levels in postmenopausal women. Hsu SC; Liu CM; Long CY; Yang CH; Lee JN; Tsai EM Fertil Steril; 2005 Oct; 84(4):1037-9. PubMed ID: 16213869 [TBL] [Abstract][Full Text] [Related]
32. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy. Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668 [TBL] [Abstract][Full Text] [Related]
33. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative. Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR; Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546 [TBL] [Abstract][Full Text] [Related]
34. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate. Uygur D; Yeşildaglar N; Erkaya S Gynecol Endocrinol; 2005 Apr; 20(4):209-12. PubMed ID: 16019363 [TBL] [Abstract][Full Text] [Related]
35. Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial. Harman SM; Brinton EA; Naftolin F; Merriam GR; Cedars MI; Freeman RG; Santoro N Ann Intern Med; 2010 Jul; 153(1):60-1; author reply 61-2. PubMed ID: 20621909 [No Abstract] [Full Text] [Related]
36. Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial. Sullivan JL Ann Intern Med; 2010 Jul; 153(1):61; author reply 61-2. PubMed ID: 20621911 [No Abstract] [Full Text] [Related]
37. Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial. Pines A; Sturdee D Ann Intern Med; 2010 Jul; 153(1):61; author reply 61-2. PubMed ID: 20621912 [No Abstract] [Full Text] [Related]
38. Summaries for patients. Postmenopausal hormone therapy and blood sugar. Ann Intern Med; 2003 Jan; 138(1):I10. PubMed ID: 12513063 [No Abstract] [Full Text] [Related]
39. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women. Ziaei S; Moaya M; Faghihzadeh S Climacteric; 2010 Jun; 13(3):249-53. PubMed ID: 19848555 [TBL] [Abstract][Full Text] [Related]
40. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. Koh KK; Mincemoyer R; Bui MN; Csako G; Pucino F; Guetta V; Waclawiw M; Cannon RO N Engl J Med; 1997 Mar; 336(10):683-90. PubMed ID: 9041098 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]